23 combined NFL seasons; four Super Bowl wins; two identical twins; one goal Independence associates tuned in on March 2 to hear New England Patriots defensive backs Devin and Jason…
Read More
Winners will receive funding for their community solutions to rising Millennial health challenges The Economy League of Greater Philadelphia (ELGP) and Independence Blue Cross (Independence) announced the Grand Prize winners…
In a story about e-bikes and bike-sharing programs, The New York Times included Indego, Philadelphia’s bike-sharing program sponsored by Independence Blue Cross. Over the next five years, the Indego system…
WHYY.org reported on published research by Independence Blue Cross and the University of Pennsylvania’s Wharton School of Business that quantified the risk of coronavirus infection. The study showed that essential…
Dr. Rodrigo Cerdá, vice president of Clinical Transformation at Independence Blue Cross, wrote an opinion piece for Managed Healthcare Executive about the need for strong relationships between health plans and providers,…
By Victor Caraballo, M.D., VP of Quality Management, Independence Blue Cross A third FDA-authorized COVID-19 vaccine The U.S. Food and Drug Administration (FDA) has officially authorized the Johnson & Johnson…
Collaboration will bring two million COVID-19 vaccines to at-risk seniors across the United States in next 100 days Independence Blue Cross (Independence) joins the White House, America’s Health Insurance Plans…
Independence Blue Cross (Independence) has announced a collaboration with Massachusetts Institute of Technology (MIT) on breakthrough developments in deep learning algorithms in health care that was published in February at…
Everyone would like the pandemic to end, but many have questions about the vaccines. Independence Blue Cross Vice President of Clinical Services Dr. Reetika Kumar reviews the facts about the…
New Blue Cross Blue Shield Association Health of America data looked at Human papillomavirus (HPV) vaccination rates over a three-year period for the commercially insured population ages 10-13. HPV is a…